Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Antares Pharma stock

Learn how to easily invest in Antares Pharma stock.

Antares Pharma is a pharmaceuticals business based in the US. Antares Pharma shares (ATRS) are listed on the NASDAQ and all prices are listed in US Dollars. Antares Pharma employs 201 staff and has a trailing 12-month revenue of around $183.5 million.

How to buy Antares Pharma stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – ATRS. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Promoted

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Antares Pharma stock price (NASDAQ: ATRS)

Use our graph to track the performance of ATRS stocks over time.

Antares Pharma shares at a glance

Information last updated 2022-11-06.
Latest market close$5.59
52-week range$3.11 - $5.60
50-day moving average $4.93
200-day moving average $3.92
Wall St. target price$5.95
PE ratio 24.0948
Dividend yield $0 (0%)
Earnings per share (TTM) $0.23

Buy Antares Pharma stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Antares Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Antares Pharma price performance over time

Historical closes compared with the close of $5.59 from 2022-05-24

1 week (2023-01-16) N/A
1 month (2022-12-23) N/A
3 months (2022-10-23) N/A
6 months (2022-07-23) N/A
1 year (2022-01-23) N/A
2 years (2021-01-27) 25.90%
3 years (2020-01-27) 39.05%
5 years (2018-01-26) 147.35%

Is Antares Pharma stock undervalued or overvalued?

Valuing Antares Pharma stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Antares Pharma's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Antares Pharma's P/E ratio

Antares Pharma's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Antares Pharma shares trade at around 24x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Antares Pharma's EBITDA

Antares Pharma's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $23.1 million.

The EBITDA is a measure of a Antares Pharma's overall financial performance and is widely used to measure a its profitability.

Antares Pharma financials

Revenue TTM $183.5 million
Operating margin TTM 10.43%
Gross profit TTM $115.7 million
Return on assets TTM 5.04%
Return on equity TTM 26.61%
Profit margin 21.9%
Book value $1.03
Market capitalisation $955.1 million

TTM: trailing 12 months

Antares Pharma share dividends

We're not expecting Antares Pharma to pay a dividend over the next 12 months.

Have Antares Pharma's shares ever split?

Antares Pharma's shares were split on a 1:5 basis on 29 January 1999. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Antares Pharma shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Antares Pharma shares which in turn could have impacted Antares Pharma's share price.

Antares Pharma share price volatility

Over the last 12 months, Antares Pharma's shares have ranged in value from as little as $3.11 up to $5.6. A popular way to gauge a stock's volatility is its "beta".

ATRS.US volatility(beta: 1.15)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Antares Pharma's is 1.1491. This would suggest that Antares Pharma's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Antares Pharma overview

Antares Pharma, Inc. , a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. It develops, manufactures, and commercializes novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto-injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto-injectors; TLANDO to treat deficiency or absence of endogenous testosterone in adult males; and drug/device products for urologic oncology, immunology, and endocrinology. The company has strategic alliances and partnerships with Pfizer Inc.

Frequently asked questions

What percentage of Antares Pharma is owned by insiders or institutions?
Currently 7.556% of Antares Pharma shares are held by insiders and 62.835% by institutions.
How many people work for Antares Pharma?
Latest data suggests 201 work at Antares Pharma.
When does the fiscal year end for Antares Pharma?
Antares Pharma's fiscal year ends in December.
Where is Antares Pharma based?
Antares Pharma's address is: 100 Princeton South, Ewing, NJ, United States, 08628
What is Antares Pharma's ISIN number?
Antares Pharma's international securities identification number is: US0366421065
What is Antares Pharma's CUSIP number?
Antares Pharma's Committee on Uniform Securities Identification Procedures number is: 583930300

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site